Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety
Clinical trial NCT05915949 · UNKNOWN
Trial details
- NCT number
- NCT05915949
- Sponsor
- Seoul National University Bundang Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2023-10-30
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.